Immunotherapy for cancer can weaken when tumor-fighting T cells become exhausted, but researchers may have found a way to keep them going longer. Scientists at Memorial Sloan Kettering Cancer Center discovered that a signaling molecule called MEK helps T cells burn through their energy while producing cancer-killing proteins. Blocking MEK helped the cells conserve energy, survive longer and remain active in the harsh environment around tumors.
מקור: Latest Science News — ScienceDaily — לכתבה המלאה
כתיבת תגובה